The use of immunostimulants in fish larval aquaculture.
The production of fish larvae is often hampered by high mortality rates, and it is believed that most of this economic loss due to infectious diseases is ca. 10% in Western European aquaculture sector. The development of strategies to control the pathogen load and immuno-prophylactic measures must be addressed further to realise the economic "potential" production of marine fish larvae and thus improve the overall production of adult fish. The innate defence includes both humoral and cellular defence mechanisms such as the complement system and the processes played by granulocytes and macrophages. A set of different substances such as beta-glucans, bacterial products, and plant constituents may directly initiate activation of the innate defence mechanisms acting on receptors and triggering intracellular gene activation that may result in production of anti-microbial molecules. These immunostimulants are often obtained from bacterial sources, brown or red algae and terrestrial fungi are also exploited as source of novel potentiating substances. The use of immunostimulants, as dietary supplements, can improve the innate defence of animals providing resistance to pathogens during periods of high stress, such as grading, reproduction, sea transfer and vaccination. The immunomodulation of larval fish has been proposed as a potential method for improving larval survival by increasing the innate responses of the developing animals until its adaptive immune response is sufficiently developed to mount an effective response to the pathogen. To this end it has been proposed that the delivery of immunostimulants as a dietary supplement to larval fish could be of considerable benefit in boosting the animals innate defences with little detriment to the developing animal. Conversely, there is a school of thought that raises the concern of immunomodulating a neotanous animal before its immune system is fully formed as this may adversely affect the development of a normal immune response.
Bricknell
Ian
I
FRS Marine Laboratory, PO Box 101, 375 Victoria Road, Torry, Aberdeen AB11 9DB, UK. i.r.bricknell@marlab.ac.uk
Dalmo
Roy A
RA
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D017756:Aquaculture / Q000379:methods*; D003140:Communicable Disease Control / Q000379:methods*; D003141:Communicable Diseases / Q000276:immunology / Q000662:veterinary*; D019587:Dietary Supplements; D005393:Fish Diseases / Q000276:immunology / Q000517:prevention & control*; D005399:Fishes; D007113:Immunity, Innate / Q000187:drug effects*; D007814:Larva / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology; D011956:Receptors, Cell Surface / Q000276:immunology; D051193:Toll-Like Receptors
D000276:Adjuvants, Immunologic; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D051193:Toll-Like Receptors